Home›Companies›Biotech & Pharma›SelSym Biotech

SelSym Biotech, Inc.

Develops a bleeding-control therapy for people injured in emergencies.

Updated Nov 10, 2026·Latest SEC filing Jul 15, 2026·Suggest an edit

About SelSym Biotech

SelSym Biotech is a private company based in Durham, North Carolina. It has reported $500,000 raised in one offering on Form D since July 2026. Its chief executive is Seema Nandi.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 2, 2026Jul 15, 2026$500,000of $1.5M target1$500KOptions, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SelSym Biotech's Form D filed Jul 15, 2026.

SN
Seema Nandi
CEO and director
WH
LL
Louis Lyon
Director

Sources

  1. SECSelSym Biotech, Inc. filing history
  2. PressPersephoni backs SelSym Biotech